Related Experiment Video
Updated: Feb 12, 2026

Cardiopulmonary Bypass in a Mouse Model: A Novel Approach
Published on: September 22, 2017
Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series
Patrick M Wieruszewski1, Scott D Nei1, Simon Maltais2
1From the Departments of Pharmacy.
Insights
High-dose vitamin C may help treat cardiac vasoplegia after heart surgery. This vitamin, essential for catecholamine synthesis, reduced vasopressor needs in three refractory patients, suggesting a novel therapeutic avenue.
Area of Science:
- Cardiology
- Pharmacology
- Biochemistry
Background:
- Cardiac vasoplegia, a common complication post-cardiopulmonary bypass, presents limited treatment options for refractory cases.
- Vasopressor-refractory vasoplegia significantly increases morbidity and mortality in cardiac surgery patients.
Observation:
- Three patients with vasopressor-refractory vasoplegia post-cardiac surgery were treated with high-dose intravenous ascorbic acid (vitamin C).
- Ascorbic acid acts as a cofactor in endogenous catecholamine synthesis.
Findings:
- All three patients demonstrated reduced vasopressor requirements after ascorbic acid administration.
- Two patients were successfully weaned off norepinephrine within 24 hours of treatment.
Implications:
- Intravenous ascorbic acid shows potential as a novel therapeutic agent for cardiac vasoplegia.
- Further rigorous prospective studies are warranted to validate these preliminary findings and establish efficacy.
Abstract:
Cardiac vasoplegia remains a significant contributor of morbidity and mortality in cardiac surgery patients after cardiopulmonary bypass. Effective therapeutic options for vasopressor-refractory vasoplegia are limited. We report 3 patients in whom we administered high-dose intravenous ascorbic acid (vitamin C), a cofactor for endogenous catecholamine synthesis, to treat vasoplegia refractory to epinephrine, vasopressin, and norepinephrine after surgery requiring cardiopulmonary bypass. Reductions in vasopressor requirements were observed in all 3 patients, and, in 2 patients, norepinephrine was completely discontinued within 24 hours. Ascorbic acid is a novel potential therapeutic option for cardiac vasoplegia that warrants rigorous prospective studies.
Related Concept Videos
Vitamins
Cardiopulmonary Resuscitation I: Adult
Resistors In Series
In a series circuit, the...
Series Resonance
Cardiopulmonary Resuscitation III: AED Use
Series and Parallel Capacitors
First, consider capacitors connected in series to a battery. In this configuration, the plate connected to the battery's positive terminal develops a positive charge, while the plate attached to the negative terminal becomes negatively charged. An equal magnitude of charge is induced on the...

